Day 1

Friday 8 November 2024

17:00 - 17:05

Welcome: Thomas Seufferlein

Session 1:

Immunotherapy

Chairs:

Jaroslaw Regula, Warsaw and Alica Beutel, Ulm

17:05 -17:35

Lecture: The spectrum of immune checkpoints in cancer (and how they can be addressed)

Leonidas Apostolidis, Heidelberg

Immunotherapy in:

17:35 - 17:55

Upper GI Cancer:

Michael Quante, Freiburg

17:55 - 18:15

Colorectal Cancer

Thomas Ettrich, Ulm

18.15 - 18.35

Hepatobiliary Cancer

Yann Touchefeu, Nantes

18:35 - 19:00

Discussion

Day 2

Saturday 9 November 2024

Session 2:

Microbiome and cancer

Chairs:

Eric Van Cutsem, Leuven and Ana-Maria Bucalau, Brussels

09:00 - 09:05

Introduction

09:05 - 09:40

Special lecture:
Microbiome and Cancer

Mathias Heikenwälder, Tübingen

Session 3:

Novel strategies in pancreatic cancer

Chairs:

Thomas Seufferlein, Ulm and Zineb Benbrahim, Fes

09:40 - 09:55

CarT cells

Christoph Stein-Thöringer, Tübingen

09:55 - 10:10

Vaccination

Naomi Hönisch Gravel, Tübingen

10:10 - 10:25

Locally advanced pancreatic carcinoma
- surgical strategy

Susanne Roth, Heidelberg

10:25 - 10:40

Locally advanced pancreatic cancer - oncology strategy

Jean-Luc van Laethem, Brussels

10:40 - 10:55

Novel targets in PDAC

Thomas Seufferlein, Ulm

10:55 - 11:10

Discussion

Session 4:

Novel strategies in cholangiocarcinoma

Chairs:

Thomas Gruenberger, Vienna and Jelena Jevtovic, Belgrade

Molecular pathology of cholangiocarcinoma

11:30 - 11:45

HER 2 and others:

Pieter-Jan Cuyle, Bonheiden

11:45 - 12:00

FGFR 2, IDH1/2:

Arndt Vogel, Toronto

12:00 - 12:15

Is there an optimal (neoadjuvant) regimen in advanced BTC?

Michael Bitzer, Tübingen

12:15 - 12:30

Discussion

      Session 5:

Novel strategies in the treatment of colorectal cancer

Chairs:

Thomas Seufferlein, Ulm and Michela Guardascione, Aviano

13:15 - 13:30

Can robotics add to a potential curative approach in CRLM?

Thomas Gruenberger, Vienna

13:30 - 13:45

Organ sparing strategies (MSI) -are we ready?

Sebastian Stintzing, Berlin

13:45 - 14:00

Multidisciplinary approaches in CRC:

Eric Van Cutsem, Leuven

14:00 - 14:15

Liquid biopsies - ready for treatment planning in CRC?

Gunnar Folprecht, Dresden

14:15 - 14:30

Discussion

Session 6:

Novel strategies outside study evidence – Molecular tumor board

Board:

T. Seufferlein., E. Van Cutsem, T. Gruenberger, J. Regula

14:50 - 15:05

Setting of a molecular tumor board

15:05 - 15:30

Molecular analysis – Panels, WES, WGS Scores

Albrecht Stenzinger, Heidelberg

15:30 - 15:40

1st case:

Michela Guardascione, Aviano

15:40 - 15:50

2nd case:

Elisabeth Stragier, Hasselt

15:50 - 16:00

3rd case:

Manuel Arce von Herold, Costa Rica

16:00 - 16:20

Discussion

Session 7:

Update – what is new in 2024

Chairs:

Pieter-Jan Cuyle, Bonheiden and Piotr Wysocki, Warsaw

16:20 - 16:30

Upper GI cancer:

Jelena Jevtovic, Belgrade

16:30 - 16:40

Colorectal cancer:

Zineb Benbrahim, Fes

16:40 - 16:50

Liver and biliary tract cancer:

Ana-Maria Bucalau, Brussels

16:50 - 17:00

Pancreatic cancer:

Alica Beutel, Ulm